Tracy is an Associate Director in the Life Sciences team at ICG focused on creating and building life science companies that address commercially attractive markets in diseases of high unmet medical need. Tracy has 20 years industry experience in venture capital, company creation and drug development. She’s spent the past 8 years of her career as an investor and was previously a Principal at Bridge Valley Ventures and an Associate at Epidarex Capital. Prior to that she worked in technology transfer at Edinburgh University and Cancer Research UK with a focus on company creation/spinout. Underpinning this is a background in drug discovery and development as a Project Manager at Quintiles and Fulcrum Pharma where she led several projects from pre-clinical to clinical development across a variety of therapeutic areas. Tracy holds a BSc in Chemistry and an MBA from the University of Strathclyde, Glasgow.